ASPECT BIOSYSTEMS LTD.

History

YearDetail
2013 Aspect Biosystems was founded from an interdisciplinary collaboration between medicine and engineering at the University of British Columbia in 2013.
2018 Aspect Biosystems collaborated with the Institute for Technology-Inspired Regenerative Medicine (MERLN) at Maastricht University in the Netherlands to focus on developing kidney tissue.
2021 Aspect Biosystems collaborated with JSR Corporation, a company specializing in advanced materials innovation, to develop implantable vascularized tissues for kidney regeneration and other applications in regenerative medicine. 
2023 Aspect Biosystems collaborated with Novo Nordisk A/S to develop bioprinted tissue therapeutics for diabetes and obesity.
AI Sentiment